Morphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 3, 2009, Pages 451-457

  Slayden, Richard A ^a   Belisle, John T ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Cefalexin; Cell division; M. tuberculosis; Microarray; Piperacillin

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; CEFALEXIN; FTSZ PROTEIN; PENICILLIN BINDING PROTEIN; PIPERACILLIN; PROTEIN FTSI; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DIVISION; CONTROLLED STUDY; DNA MICROARRAY; DRUG PROTEIN BINDING; DRUG TARGETING; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENE MAPPING; GENE OVEREXPRESSION; GENE TARGETING; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TRANSCRIPTION INITIATION;

BACTERIAL PROTEINS; CELL DIVISION; CEPHALEXIN; GENE EXPRESSION PROFILING; GROWTH INHIBITORS; MICROSCOPY; MICROSCOPY, ELECTRON, SCANNING; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PIPERACILLIN;

EID: 60649107144     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn507     Document Type: Article

References (28)

1. Slayden RA, Knudson DL, Belisle JT. Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis. Microbiology 2006; 152: 1789-97.
2. Zhang Y, Post-Martens K, Denkin S. New drug candidates and therapeutic targets for tuberculosis therapy. Drug Discov Today 2006; 11 21-7.
3. Zhang Y, Amzel LM. Tuberculosis drug targets. Curr Drug Targets 2002; 3: 131-54.
4. Barry CE 3rd, Slayden RA, Sampson AE et al. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. Biochem Pharmacol 2000; 59: 221-31.
5. Slayden RA, Crick D, Neil MM et al. Genomics in tuberculosis drug discovery. The Role of Genomics in Antibacterial Drug Discovery. New York: Marcel Dekker, 2003; 111-34.
6. Respicio L, Nair PA, Huang Q et al. Characterizing septum inhibition in Mycobacterium tuberculosis for novel drug discovery. Tuberculosis (Edinb) 2008; 88: 420-9.
7. Errington J, Daniel RA, Scheffers DJ. Cytokinesis in bacteria. Microbiol Mol Biol Rev 2003; 67: 52-65.
8. Eberhardt C, Kuerschner L, Weiss DS. Probing the catalytic activity of a cell division-specific transpeptidase in vivo with β-lactams. J Bacteriol 2003; 185: 3726-34.
9. Pogliano J, Pogliano K, Weiss DS et al. Inactivation of FtsI inhibits constriction of the FtsZ cytokinetic ring and delays the assembly of FtsZ rings at potential division sites. Proc Natl Acad Sci USA 1997; 94: 559-64.
10. Maki N, Gestwicki JE, Lake EM et al. Motility and chemotaxis of filamentous cells of Escherichia coli. J Bacteriol 2000; 182 4337-42.
11. Gullbrand B, Akerlund T, Nordstrom K. On the origin of branches in Escherichia coli. J Bacteriol 1999; 181: 6607-14.
12. Wang F, Cassidy C, Sacchettini JC. Crystal structure and activity studies of the Mycobacterium tuberculosis β-lactamase reveal its critical role in resistance to β-lactam antibiotics. Antimicrob Agents Chemother 2006; 50: 2762-71.
13. Chambers HF, Moreau D, Yajko D et al. Can penicillins and other β-lactam antibiotics be used to treat tuberculosis? Antimicrob Agents Chemother 1995; 39: 2620-4.
14. Jarlier V, Nikaido H. Mycobacterial cell wall: Structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 1994; 123: 11-8.
15. Zhang Y, Steingrube VA, Wallace RJ Jr. β-Lactamase inhibitors and the inducibility of the β-lactamase of Mycobacterium tuberculosis. Am Rev Respir Dis 1992; 145: 657-60.
16. Abate G, Miorner H. Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol. J Antimicrob Chemother 1998; 42 735-40.
17. Flores AR, Parsons LM, Pavelka MS Jr. Characterization of novel Mycobacterium tuberculosis and Mycobacterium smegmatis mutants hypersusceptible to β-lactam antibiotics. J Bacteriol 2005; 187: 1892-900.
18. Flores AR, Parsons LM, Pavelka MS Jr. Genetic analysis of the β-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to β-lactam antibiotics. Microbiology 2005; 151: 521-32.
19. Huang Q, Kirikae F, Kirikae T et al. Targeting FtsZ for antituberculosis drug discovery: Noncytotoxic taxanes as novel antituberculosis agents. J Med Chem 2006; 49: 463-6.
20. Romberg L, Levin PA. Assembly dynamics of the bacterial cell division protein FTSZ: Poised at the edge of stability. Annu Rev Microbiol 2003; 57: 125-54.
21. Wang L, Lutkenhaus J. FtsK is an essential cell division protein that is localized to the septum and induced as part of the SOS response. Mol Microbiol 1998; 29: 731-40.
22. Weiss DS, Chen JC, Ghigo JM et al. Localization of FtsI (PBP3) to the septal ring requires its membrane anchor, the Z ring, FtsA, FtsQ, and FtsL. J Bacteriol 1999; 181: 508-20.
23. Goehring NW, Gueiros-Filho F, Beckwith J. Premature targeting of a cell division protein to midcell allows dissection of divisome assembly in Escherichia coli. Genes Dev 2005; 19: 127-37.
24. Katis VL, Harry EJ, Wake RG. The Bacillus subtilis division protein DivIC is a highly abundant membrane-bound protein that localizes to the division site. Mol Microbiol 1997; 26: 1047-55.
25. Boshoff HI, Myers TG, Copp BR et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: Novel insights into drug mechanisms of action. J Biol Chem 2004; 279 40174-84.
26. Gullbrand B, Nordstrom K. FtsZ ring formation without subsequent cell division after replication runout in Escherichia coli. Mol Microbiol 2000; 36: 1349-59.
27. Wilson M, DeRisi J, Kristensen H-K et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA 1999; 96: 12833-8.
28. Lee RE, Protopopova M, Crooks E et al. Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates. J Comb Chem 2003; 5 172-87.